1. WHO. Cardiovascular disease. Newsletter No. 317, January 2015. http://www.who.int/ mediacentre/factsheets/fs317/ru/ (In Russ.).
2. Grebenchikov O.A., Likhvantsev V.V., Plotnikov E.Yu., Silachev D.N., Pevzner I.B., Zorova L.D. et al. Molecular mechanisms of ischemic-reperfusion syndrome and its therapy. Russian Journal of Anаеsthesiology and Reanimatology. 2014;3:59–67 (In Russ.).
3. Shlyakhto E.V., Nifontov E.M., Galagudza M.M. Limitation of ischemic and reperfusion myocardial damage by pre-and postconditioning: molecular mechanisms and targets for pharmacotherapy. Creative Cardiology. 2007;1–2:75–101 (In Russ.).
4. Chukicheva I.Yu., Kuchin A.V. Natural and synthetic terpenophenols. Russian Journal of General Chemistry. 2004;48(3):21–37 (In Russ.).
5. Plotnikov M.B., Chernysheva G.A., Smol’yakova V.I., Ivanov I.S., Kuchin A.V., Chukicheva I.Yu. et al. Neuroprotective effects and mechanisms of action of dibornol in cerebral ischemia. Annals of the Russian Аcademy of Мedical Sciences. 2009;11:12–17 (In Russ.).